Organometallics
Article
H, Ar−H), 7.76−7.73 (m, 1 H, Ar−H), 7.67−7.58 (m, 4 H, Ar−H),
7.57−7.55 (m, 1 H, Ar−H), 7.46−7.43 (m, 2 H, Ar−H), 7.39−7.36
21.1, 20.3 (CH3). Anal. Calcd for C31H37Br2N5Pd: C, 49.92; H, 5.00;
N, 9.39; found: C, 50.89; H, 5.30; N, 9.55.57 MS (ESI, m/z): calcd for
[M − Br]+, C31H37BrN5Pd, m/z 666; found, m/z 666.
2
(m, 1 H, Ar−H), 6.12 (d, JH−H = 15 Hz, 1 H, NCHH), 5.72 (d,
Synthesis of trans-[PdBr2(iPr2-bimy)(Ph-tazy)] (8). The compound
was prepared in a manner similar to 6 with C (160 mg, 0.5 mmol),
silver(I) oxide (130 mg, 0.55 mmol), and [PdBr2(iPr2-bimy)] (235
mg, 0.25 mmol). Yield: 290 mg (0.41 mmol, 82%). 1H NMR (CDCl3,
2JH−H = 15 Hz, 1 H, NCHH), 2.87 (s, 3 H, CH3), 2.23 (s, 3 H, CH3).
Second isomer: 8.15−8.13 (m, 2 H, Ar−H, NCHN), 8.01−7.98 (m, 1
H, Ar−H), 7.76−7.73 (m, 1 H, Ar−H), 7.70 (d, 1 H, Ar−H), 7.67−
7.58 (m, 4 H, Ar−H), 7.57−7.55 (m, 1 H, Ar−H), 7.46−7.43 (m, 2
H, Ar−H), 7.39−7.36 (m, 1 H, Ar−H), 6.28 (d, 2JH−H = 15 Hz, 1 H,
3
500 MHz): δ = 8.15 (s, 1 H, NCHN), 7.97 (d, JH−H = 7.8 Hz, 2 H,
3
2
Ar−H), 7.76 (d, JH−H = 7.4 Hz, 2 H, Ar−H), 7.64−7.57 (m, 3 H,
NCHH), 5.66 (d, JH−H = 15 Hz, 1 H, NCHH), 2.83 (s, 3 H, CH3),
3
2.68 (s, 3 H, CH3). 13C NMR (CDCl3, 126.7 MHz): δ = (152.9,
152.2) (Ccarbene), (144.5, 144.1) (NCNH), 132.5, 131.8, 131.7, 131.4,
130.0, 129.7 (2 C), 129.6 (2 C), 129.5, 129.3 (2 C), 129.2 (2 C),
128.8, 128.7, 128.5 (2 C), 128.0 (2 C), 126.8, 126.4, 124.7 (2 C),
124.4, 124.2, 123.0 (2 C) (Ar−C), 57.3 (2 C, NCH2), 45.6, 45.4,
45.3, 45.2 (CH3). Anal. Calcd for C21H21Cl2N3OPtS: C, 40.07; H,
3.36; N, 6.68; found: C, 40.31; H, 3.10; N, 6.38. MS (ESI, m/z): calcd
for [M − Cl]+, C21H21ClN3OPtS, m/z 594; found, m/z 594; calcd for
[M + H2O]+, C21H23Cl2N3O2PtS, m/z 647; found, m/z 647.
Ar−H), 7.53−7.49 (m, 2 H, Ar−H), 7.45 (t, JH−H = 7.8 Hz, 2 H,
3
Ar−H), 7.39 (t, JH−H = 7.4 Hz, 1 H, Ar−H), 7.18−7.16 (m, 2 H,
Ar−H), 6.02−5.94 (m, 3 H, CH(CH3)2 and NCH2), 5.74 (sept,
3JH−H = 7.1 Hz, 1 H, CH(CH3)2), 1.73 (d, 3JH−H = 7.1 Hz, 6 H, CH3),
1.55 (d, 3JH−H = 7.1 Hz, 6 H, CH3). 13C NMR (CDCl3, 126.7 MHz):
δ = 177.0, 176.2 (Cprobe), 142.9, 137.2, 135.5, 134.2, 134.0, 129.9,
129.9, 129.8, 129.4, 129.1, 127.30, 122.7, 113.2 (Ar−C), 57.4
(NCH2), 54.5, 54.3 (CH(CH3)2), 21.7, 21.3 (CH3). Anal. Calcd for
C28H31Br2N5Pd·2H2O: C, 45.46; H, 4.77; N, 9.47; found: C, 45.81;
H, 4.26; N, 9.93.57 MS (ESI, m/z): calcd for [M − Br]+,
C28H31BrN5Pd, m/z 624; found, m/z 624. HR-MS (ESI, m/z):
calcd for [M − Br]+, C28H31BrN5Pd, m/z 624.0719; found, m/z
624.0709.
Synthesis of cis-[PtCl2(DMSO)(Bn-tazy)] (5). The compound was
prepared in a manner similar to 1 from E (165 mg, 0.5 mmol),
silver(I) oxide (65 mg, 0.28 mmol, 0.55 equiv), and potassium
tetrachloroplatinate(II) (207 mg, 0.5 mmol, 1 equiv). Yield: 250 mg
1
(0.42 mmol, 84%). H NMR (CDCl3, 500 MHz): δ = 7.88 (s, 1 H,
Synthesis of trans-[PdBr2(iPr2-bimy)(Nap-tazy)] (9). The com-
pound was prepared in a manner similar to 6 with D (180 mg, 0.5
mmol), silver(I) oxide (130 mg, 0.55 mmol), and [PdBr2(iPr2-bimy)]
2
NCHN), 7.44−7.33 (m, 10 H, Ar−H), 5.77 (d, JH−H = 15 Hz, 1 H,
CHH), 5.68 (d, 2JH−H = 15 Hz, 1 H, CHH), 5.62 (d, 2JH−H = 15 Hz, 1
2
1
H, CHH), 5.56 (d, JH−H = 15 Hz, 1 H, CHH), 3.13 (s, 3 H, CH3),
(235 mg, 0.25 mmol). Yield: 295 mg (0.39 mmol, 78%). H NMR
3.00 (s, 3 H, CH3). 13C NMR (CDCl3, 126.7 MHz): δ = 151.2
(NCN), 143.3 (NCN), 135.2, 134.1, 130.0, 129.8, 129.6, 129.3,
129.2, 129.1 (Ar−C), 56.9 (NCH2), 53.1 (NCH2), 46.1 (CH3), 45.9
(CH3). Anal. Calcd for C18H21Cl2N3OPtS·H2O: C, 35.36; H, 3.79; N,
6.87; found: C, 35.70; H, 3.46; N, 7.18. MS (ESI, m/z): calcd for [M
− Cl]+, C18H21ClN3OPtS, m/z 558; found, m/z 558 (15%); calcd for
[M + H2O]+, C18H23Cl2N3O2PtS, m/z 611; found, m/z 611 (100%).
Synthesis of trans-[PdBr2(iPr2-bimy)(Dipp-tazy)] (6). A mixture of
A (200 mg, 0.5 mmol), silver(I) oxide (130 mg, 0.55 mmol), and
[PdBr2(iPr2-bimy)] (235 mg, 0.25 mmol) was suspended in
dichloromethane (10 mL) and stirred at ambient temperature for 5
h shielded from light. The precipitate was then removed by filtration
over a short plug of Celite. After removing the solvent, the solid
obtained was subjected to purification using silica gel column
chromatography and DCM as the eluent. The product was isolated
(CDCl3, 500 MHz): δ = 7.17 (s, 1 H, NCHN), 8.11 (d, 1 H, Ar−H),
8.04−8.02 (m, 1 H, Ar−H), 7.97 (d, 1 H, Ar−H), 7.89−7.87 (m, 1 H,
Ar−H), 7.82 (m, 2 H, Ar−H), 7.69−7.63 (m, 3 H, Ar−H), 7.49−7.46
(m, 3 H, Ar−H), 7.41 (t, 1 H, Ar−H), 7.35−7.33 (m, 1 H, Ar−H),
7.14−7.08 (m, 2 H, Ar−H), 6.22 (brd. d, 1 H, NCH2), 5.92−5.86 (m,
3
2 H, NCH2 and CH(CH3)2), 4.92 (sept., JH−H = 7.0 Hz, 1 H,
3
CH(CH3)2), 1.70 (d, JH−H = 7.0 Hz, H, CH3), 1.18 (brd. s, 3 H,
CH3), 1.06 (brd. s, 3 H, CH3). 13C NMR (CDCl3, 126.7 MHz): δ =
177.8, 176.6 (Cprobe), 144.4, 135.8, 134.7, 134.1, 133.9, 133.0, 130.8,
130.0, 129.9 (2 C), 129.5 (2 C), 129.1, 128.5, 128.4, 127.9, 127.8,
125.5, 124.9, 122.5, 113.1, 113.0 (Ar−C), 57.5 (NCH2), 54.4, 53.9
(CH(CH3)2), 21.6 (CH3). Anal. Calcd for C32H33Br2N5Pd: C, 50.98;
H, 4.41; N, 9.29; found: C, 50.90; H, 4.90; N, 9.00.57 MS (ESI, m/z):
calcd for [M − Br]+, C32H33BrN5Pd, m/z 674; found, m/z 674. HR-
MS (ESI, m/z): calcd for [M − Br]+, C32H33BrN5Pd, m/z 674.0875;
found, m/z 674.0877.
1
as a pale yellow solid. Yield: 350 mg (0.44 mmol, 88%). H NMR
3
(CDCl3, 500 MHz): δ = 7.98 (s, 1 H, NCHN), 7.77 (d, JH−H = 8.0
Hydration of Phenylacetylene Reaction. In a typical run, a
Schlenk tube was charged with a mixture of 0.5 mmol of
phenylacetylene, an appropriate amount of the catalyst, and solvent
(1.5 mL). The mixture was then stirred at the appropriate
temperature for the required time. The product was then extracted
with dichloromethane (3 × 2 mL). The combined extracts were
Hz, 2 H, Ar−H), 7.57 (t, 3JH−H = 8.0 Hz, 1 H, Ar−H), 7.51−7.45 (m,
3 H, Ar−H), 7.43−7.36 (m, 4 H, Ar−H), 7.15−7.10 (m, 2 H, Ar−H),
6.07 (s, 2 H, NCH2), 5.97 (brd. s, 1 H, CH(CH3)2), 5.39 (brd. s, 1 H,
CH(CH3)2), 2.99 (sept, 3JH−H = 6.8 Hz, 2 H, CH(CH3)2), 1.71 (brd.
3
s, 6 H, CH3), 1.39 (d, 3JH−H = 6.8 Hz, 12 H, CH3), 1.01 (d, JH−H
=
6.8 Hz, 6 H, CH3). 13C NMR (CDCl3, 126.7 MHz): δ = 178.1, 176.4
(Cprobe), 147.9, 145.1, 135.8, 132.4, 131.2, 129.9 (2 C), 129.5, 129.0,
124.5, 122.5, 112.9 (Ar−C), 57.7 (NCH2), 30.4, 29.3 (CH(CH3)2),
27.3, 23.1, 21.4 (CH3). Anal. Calcd for C34H43Br2N5Pd: C, 51.83; H,
5.50; N, 8.89; found: C, 52.37; H, 5.53; N, 8.69.57 MS (ESI, m/z):
calcd for [M − Br]+, C34H43BrN5Pd, m/z 708; found, m/z 708. HR-
MS (ESI, m/z) calcd for [M − Br]+, C34H43BrN5Pd, m/z 708.1658;
found, m/z 708.1667.
subjected to H NMR to determine the reaction yields.
1
Hydrosilylation of Phenylacetylene Reaction. In a typical run,
a Schlenk tube was charged with a mixture of 2 mmol of
phenylacetylene, 2.2 mmol of bis(trimethylsiloxy)methylsilane, an
appropriate amount of catalyst, and 1 mL of toluene as solvent. The
mixture was then stirred at the appropriate temperature for the
required time. The solvent was then removed under reduced pressure,
1
and the crude products were then subjected to H NMR analysis to
Synthesis of trans-[PdBr2(iPr2-bimy)(Mes-tazy)] (7). The com-
pound was prepared in a manner similar to 6 with B (180 mg, 0.5
mmol), silver(I) oxide (130 mg, 0.55 mmol), and [PdBr2(iPr2-bimy)]
determine the reaction yields.
X-ray Crystallography. Single-crystal X-ray diffraction were
collected on a Bruker D8 QUEST instrument at 298 K with Mo
Kα radiation (λ = 0.71073 Å) using a TRIUMPH monochromator.
Standard procedures were applied for data reduction and absorption
correction.58,59 Structure solution and refinement were performed
with the SHELXT and SHELXL 2014/7 programs.60,61 Hydrogen
atoms were calculated for idealized positions and treated with the
“riding model” option of SHELXL. The representation of molecular
structures was done using the program OLEX2-1.2.62
Computation. Gas-phase structures of all complexes were
optimized by DFT methods using the B3PW91 hybrid functional63,64
with the 6-31G(d)65 basis set applied for light atoms, whereas the
heavy atom Pt was described by the Stuttgart-Dresden (SDD)
1
(235 mg, 0.25 mmol). Yield: 300 mg (0.4 mmol, 80%). H NMR
3
(CDCl3, 500 MHz): δ = 7.92 (s, 1 H, NCHN), 7.72 (d, JH−H = 7.4
Hz, 2 H, Ar−H), 7.52−7.50 (m, 1 H, Ar−H), 7.47−7.43 (m, 3 H,
3
Ar−H), 7.38 (t, JH−H = 7.4 Hz, 1 H, Ar−H), 7.16−7.14 (m, 2 H,
Ar−H), 7.09 (s, 2 H, Ar−H), 6.00 (s, 2 H, NCH2), 5.87 (sept, 3JH−H
3
= 7.0 Hz, 1 H, CH(CH3)2), 5.58 (sept, JH−H = 7.0 Hz, 1 H,
CH(CH3)2), 2.43 (s, 3 H, CH3), 2.33 (s, 6 H, CH3), 1.72 (d, 3JH−H
=
3
7.0 Hz, 6 H, CH3), 1.47 (d, JH−H = 7.0 Hz, 6 H, CH3). 13C NMR
(CDCl3, 126.7 MHz): δ = 177.5, 176.1 (Cprobe), 144.1, 140.2, 137.1,
136.1, 134.2, 134.1, 132.8, 129.7, 129.6, 129.4, 128.9, 122.5, 113.19,
112.9 (Ar−C), 57.5 (NCH2), 54.5, 53.9 (CH(CH3)2), 21.8, 21.6,
H
Organometallics XXXX, XXX, XXX−XXX